The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...
Use of IV immunoglobulin was associated with a significantly reduced ICU length of stay in immunocompromised patients with respiratory viral infections.
A new COVID variant, XEC, is gaining traction in the U.S. and is estimated to account for up to 13% of cases. The strain is a recombinant of two JN.1 lineage viruses, with new COVID shots expected to ...